mTOR Pathway Mutations and Response to Rapalogs in RCC-Letter

Clin Cancer Res. 2017 Sep 1;23(17):5320. doi: 10.1158/1078-0432.CCR-17-1280.

Juan M Roldan-Romero¹, Juan F Rodríguez-Moreno^{2

3}, Jesus García-Donás^{4

3}, Cristina Rodríguez-Antona^{5

6}

¹ Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
² Genitourinary and Gynecological Cancer Unit, Clara Campal Comprehensive Cancer Center, Madrid, Spain.
³ Spanish Oncology GenitoUrinary Group (SOGUG), Spain.
⁴ Genitourinary and Gynecological Cancer Unit, Clara Campal Comprehensive Cancer Center, Madrid, Spain. crodriguez@cnio.es jgarciadonas@gmail.com.
⁵ Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. crodriguez@cnio.es jgarciadonas@gmail.com.
⁶ Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

No abstract available

Publication types